Bausch Health Companies Inc reports results for the quarter ended June 30 - Earnings Summary
Bausch Health Companies Inc reports results for the quarter ended June 30 - Earnings Summary
Bausch Health Companies Inc BHC.TO reported quarterly adjusted earnings of $1.26 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 91 cents. The mean expectation of three analysts for the quarter was for earnings of $1.04 per share. Wall Street expected results to range from 93 cents to $1.20 per share.
Revenue rose 12.7% to $2.85 billion from a year ago; analysts expected $2.66 billion.
Bausch Health Companies Inc's reported EPS for the quarter was 68 cents.
The company reported quarterly net income of $258 million.
Bausch Health Companies Inc shares had fallen by 8.4% this quarter and lost 32.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 2% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."
This summary was machine generated from LSEG data July 29 at 10:40 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 1.04 | 1.26 | Beat |
Mar. 31 2026 | 0.69 | 0.78 | Beat |
Dec. 31 2025 | 1.26 | 1.10 | Missed |
Sep. 30 2025 | 1.12 | 1.16 | Beat |
Recent news on Bausch Health Companies
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: Bausch Health Companies -Co And Yun Expand Strategic Collaboration In Mexico And EMEA Markets
Canada Stocks: Toronto stocks near record high as investors weigh earnings, US PPI data